To determine in vivo expression of the NKG2D and DNAM-1 ligands on RMS tumor cells, biopsy sections of 8 ERMS patients taken at diagnosis were stained for ULBP-1, MICA, CD112 and CD155 (Table 2; Fig. 2). This evidence concerns the gene MICA and embryonal rhabdomyosarcoma.